Intended for healthcare professionals
Our CompanySubscribeMy AccountLogin

Maternal opioid treatment after delivery and risk of adverse infant outcomes

mother and newborn
mother and newborn

Maternal opioid treatment after delivery and risk of adverse infant outcomes

New research suggests no association between maternal opioid prescription after delivery and adverse infant outcomes

EditorialOpioid analgesia for breastfeeding mothers
semaglutide
Semaglutide: should the media slim down its enthusiasm?

When drug semaglutide gained NICE approval for weight loss last week, the press response was largely positive. Margaret McCartney reports

feature  |  Mar 17
Semaglutide: should the media slim down its enthusiasm?

When drug semaglutide gained NICE approval for weight loss last week, the press response was largely positive. Margaret McCartney reports

semaglutide
feature

Mar 17

Latest articles

News

NHS strikes

UK Jobs

Birmingham and Solihull Mental Health NHS Foundation Trust: Consultant Psychiatrist General Adult - Northcroft CMHT

Current issue

latest issue
All articlesPast issues

Most read

1.

Community

Latest responses

View more

What are your thoughts?

Altmetrics

Altmetric Badge
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial: Video 1
Nov 2, 2021